J. B. J. Zapanta and C. V. Gorospe, “Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer after Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report”, Asian Pac J Cancer Care, vol. 10, no. 3, pp. 989–992, Jul. 2025.